Gene Therapy for Fanconi Anemia, Complementation Group A

Study sponsor: Rocket Pharmaceuticals Inc. · RCKT

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.